BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 9657046)

  • 1. Physiological mechanism-based analysis of dose-dependent gastrointestinal absorption of L-carnitine in rats.
    Matsuda K; Yuasa H; Watanabe J
    Biopharm Drug Dispos; 1998 Oct; 19(7):465-72. PubMed ID: 9818713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saturable small intestinal drug absorption in humans: modeling and interpretation of cefatrizine data.
    Yu LX; Amidon GL
    Eur J Pharm Biopharm; 1998 Mar; 45(2):199-203. PubMed ID: 9704917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ageing on the oral absorption of D-xylose in rats: analysis of gastrointestinal disposition.
    Yuasa H; Kawanishi K; Watanabe J
    J Pharm Pharmacol; 1995 Jul; 47(7):576-80. PubMed ID: 8568624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent gastrointestinal absorption of 5-fluorouracil in rats in vivo.
    Yuasa H; Matsuda K; Gu J; Suzuki E; Yokouchi I; Watanabe J
    Biol Pharm Bull; 1996 Nov; 19(11):1494-8. PubMed ID: 8951171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative absorption following the administration of a drug to rats by oral gavage and incorporation in the diet.
    Van Harken DR; Hottendorf GH
    Toxicol Appl Pharmacol; 1978 Feb; 43(2):407-10. PubMed ID: 635927
    [No Abstract]   [Full Text] [Related]  

  • 6. Dose dependency in the gastrointestinal absorption of cefatrizine: correlation between in vivo and in situ.
    Matsuda K; Yuasa H; Watanabe J
    Biol Pharm Bull; 1998 Jun; 21(6):604-9. PubMed ID: 9657046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug absorption in gastrointestinal disease with particular reference to malabsorption syndromes.
    Parsons RL
    Clin Pharmacokinet; 1977; 2(1):45-60. PubMed ID: 322910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethanol-drug absorption interaction: potential for a significant effect on the plasma pharmacokinetics of ethanol vulnerable formulations.
    Lennernäs H
    Mol Pharm; 2009; 6(5):1429-40. PubMed ID: 19655809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal transit and drug absorption.
    Kimura T; Higaki K
    Biol Pharm Bull; 2002 Feb; 25(2):149-64. PubMed ID: 11853157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal solute carriers: an overview of trends and strategies for improving oral drug absorption.
    Steffansen B; Nielsen CU; Brodin B; Eriksson AH; Andersen R; Frokjaer S
    Eur J Pharm Sci; 2004 Jan; 21(1):3-16. PubMed ID: 14706808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers.
    Xu Y; Shrestha N; Préat V; Beloqui A
    Adv Drug Deliv Rev; 2021 Aug; 175():113795. PubMed ID: 33989702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of oral cephalosporins.
    Stoeckel K; Hayton WL; Edwards DJ
    Antibiot Chemother (1971); 1995; 47():34-71. PubMed ID: 8554307
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.